Sarcoma
📧 Sign up to get email alerts when something new happens for Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-18Clinical Trial Update: Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease [Phase 2]
A Phase 2 trial evaluating high-dose intravenous ascorbic acid in measurable solid tumors has been withdrawn, sponsored by Situs Cancer Rese…
-
CLINICAL_TRIALS withdrawal · 2024-10-28Clinical Trial Update: CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas [Phase 1]
Phase 1 clinical trial update for CCT301-38 CAR-T in relapsed or refractory AXl-positive sarcomas has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-07-05Clinical Trial Update: Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures
A clinical trial evaluating autologous natural killer cell therapy in primary cancer cell cultures for sarcoma has been withdrawn.
-
EMA withdrawal · 2021-01-11EMA Withdrawn: Panretin (alitretinoin) — Eisai GmbH
The EMA has withdrawn Panretin (alitretinoin) from the European market, with Eisai GmbH as the marketing authorization holder, for indicatio…
-
EMA withdrawal · 2019-09-02EMA Revoked: Lartruvo (olaratumab) — Eli Lilly Nederland B.V.
The EMA revoked the marketing authorization for Larotruvo (olaratumab) by Eli Lilly Nederland B.V., effectively withdrawing approval for its…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy [Phase 1]
A Phase 1 trial evaluating adjuvant oral decitabine and tetrahydrouridine, with or without celecoxib, in patients undergoing pulmonary metas…
-
CLINICAL_TRIALS withdrawal · 2017-10-06Clinical Trial Update: Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma [NA]
A clinical trial evaluating patient-derived xenograft modeling in adults with metastatic or recurrent sarcoma was terminated. No efficacy re…
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Adoptive Therapy Using Antigen-Specific CD4 T-Cells [Phase 1]
A Phase 1 trial of adoptive therapy using antigen-specific CD4 T-cells for melanoma and sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 trial of RO4929097 in children with relapsed/refractory solid or CNS tumors, lymphoma, or T-cell leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors [Phase 1]
A Phase I study of pazopanib as a single agent for children with refractory solid tumors has been withdrawn from the trial program.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CT-011 and a p53 genetic vaccine for advanced solid tumors was withdrawn; the study encompassed breast cancer, co…
-
CLINICAL_TRIALS withdrawal · 2015-12-03Clinical Trial Update: Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor [Phase 2]
A Phase 2 pediatric trial evaluating chemotherapy followed by peripheral stem cell transplantation for newly diagnosed brain tumors has been…
-
CLINICAL_TRIALS withdrawal · 2015-10-22Clinical Trial Update: Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy
Compassionate-use program for aldoxorubicin in sarcoma patients is no longer available.
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer [NA]
A clinical trial evaluating celecoxib for pain, weight loss, and weakness in advanced cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-11Clinical Trial Update: New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma [Phase 1, Phase 2]
This clinical trial update notes that the Newcastle Disease Virus (NDV) therapy trial for Glioblastoma, Sarcoma, and Neuroblastoma has been …
-
CLINICAL_TRIALS withdrawal · 2015-05-21Clinical Trial Update: Adjuvant Valproate for High Grade Sarcomas [Phase 1]
Phase 1 trial of adjuvant valproate for high-grade sarcoma has been terminated. Sponsor: Columbia University.
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors [NA]
This clinical trial update indicates that Vanderbilt University’s study on early enteral tube feedings for children undergoing chemotherapy …
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma [NA]
The clinical trial assessing whether glutamine prevents oral mucositis in patients receiving chemotherapy for sarcoma has been withdrawn.